Sanaria’s CEO Interviewed About Development of a COVID-19 Vaccine
More than 130 labs around the world are working to develop a COVID-19 vaccine. But what would it take to vaccinate everyone by early next year?
Sanaria Recognized for Global Health Partnership in the Fight Against Malaria in BioBuzz
The ultimate goal for Sanaria is eradication of malaria from the planet. What started as a shot in the dark, cold call from Sanaria, has evolved into truly remarkable global health collaboration with Marathon Oil, Noble Energy, AMPCO, and the Government of Equatorial Guinea, that has the potential to fundamentally change the world for the better.
Sanaria and Protein Potential Recognized for Efforts Against COVID-19 in BioBuzz
Sanaria and Protein Potential, which are co-located in Rockville, Maryland, are working on a number of initiatives to combat COVID-19. Dr. Stephen L. Hoffman is the CEO and Chief Scientific Officer at Sanaria, which is a leading global malaria vaccine biotechnology company. Dr. Kim Lee Sim is the President and Chief Scientific Officer at Protein Potential, an R&D group focused on vaccine development and innovative DNA and protein products. She is also the Executive Vice President of Process Development and Manufacturing at Sanaria.
Sanaria and its Bioko Island Malaria Elimination Project partners win the Concordia P3 Impact Award and Audience Choice Award
The Bioko Island Malaria Elimination Project (BIMEP) is a long-term partnership dedicated since 2004 to the elimination of malaria from Equatorial Guinea which had one of the highest rates of malaria transmission and where the disease was the leading cause of morbidity and mortality.
New film, Hope for Bioko, showcases Sanaria’s work
Fifteen years of malaria control on Bioko Island, initially by Medical Care Development International and later Sanaria Inc., represents one of the most progressive and successful Corporate Social Responsibility projects in the Global Health arena. The CSR partners in this program include Marathon Oil, Noble Energy, Equatorial Guinea Liquefied Natural Gas and Atlantic Methanol, and the important public sector financing and involvement has come from the Government of Equatorial Guinea.
Could This Be the First Malaria Vaccine?
US News & World Report features a story on Sanaria's new finding that our experimental vaccine against malaria has provided protection for some against the illness for more than a year.
Sanaria’s Executive VP of Manufacturing and Process Development, Dr. B. Kim Lee Sim, featured in Malaymail
At a recent photoshoot by legendary photographer Annie Leibovitz of prominent scientists honoured by the Bill & Melinda Gates Foundation, one woman stood out from the rest. Dr Betty Sim Kim Lee is the president and leading researcher of an organisation working on the development of vaccines for infectious diseases. She is also a Malaysian, a proud Nyonya born and bred in Kota Bharu. So, how did this small town girl become one of the most important malaria fighters in the world today?
Explainer: GSK submits to EMA; Sanaria takes different approach
GSK submitted a regulatory application to the European Medicines Agency for its malaria vaccine candidate, RTS,S. Sanaria and GSK's different approaches are explained in this Wall Street Journal article.
Biology grad helping develop breakthrough malaria vaccine
A long sought-after vaccine for malaria, a disease that killed 660,000 people and infected more than 200 million others in 2010, is one huge step closer, thanks to a promising breakthrough developed in part by Peter Billingsley, PhD’85 (Biology).
Sanaria is a proud sponsor of Frontiers in Science and Medicine Day 2013
600 participated in fifth annual Frontiers in Science and Medicine Day.
Dr. Hoffman vs. the Mosquito
A Rockville scientist has spent 30 years struggling to eradicate malaria, the deadly insect-borne disease that has outwitted generations of medical researchers. Experts have long called his vaccine a fantasy. Now he has one last chance to prove himself.
Sanaria featured in BBC News story, A Faster Path to a Possible Malaria Vaccine
Malaria kills more than 650,000 people every year and scientists say they are close to finding a vaccine, but the method of testing for a vaccine has long been time-consuming and risky to transport. Now Sanaria, a biotechnology firm based in the US state of Maryland, has developed the first injectable form of malaria, speeding up clinical trials, reducing the time it could take to develop a vaccine and helping researchers more easily share their work. Read more and watch the video from the BBC.
Injectable parasites controlling infection, featured in Healio
In the latest edition of Healio, the health care specialist publication reports on Sanaria’s abstract at ASTMH and the concept of injectable parasites being able to control malaria infections.|
Future Montgomery workforce experiments with science, medicine
Sanaria has been featured in The Washington Post about an event for local students to give them experience with science outside the classroom. Read more about what a great time we had!|
The Quest for a Malaria Vaccine and the Man Who Risked Everything to Find It
Dr. Stephen Hoffman learned about malaria the hard way—by rolling up his sleeves and letting thousands of infected mosquitoes bite him.
Back in mid-1990s, Stephen Hoffman dipped his arm into a swarm of malaria-infected mosquitoes. But he didn’t expect to get sick. At the time, he thought he’d invented a vaccine that would keep him disease free.
He was wrong.
Helping small businesses create jobs
Rep. Chris Van Hollen has written an Op-Ed in Politico about his efforts to help small businesses like Sanaria create good, quality jobs in Maryland. Read the full story!|
Why a Man Let 2,000 Malaria-Infected Mosquitoes Bite Him
Some people will go to extreme lengths to avoid mosquito bites. They'll wear long sleeves and pants in the heat of summer, surround themselves with citronella candles and torches, and spray foul-smelling chemicals all over their bodies—or simply not set foot outside when they know the bugs are biting. Stephen Hoffman isn't quite like those people.
Pulling malaria from mosquitoes to fight disease
Think your job's tedious? Try beheading 100 mosquitoes an hour. Gently, no smushing allowed. Malaria parasites lurk in these mosquitoes' salivary glands, and a small company on the outskirts of the nation's capital needs them unharmed for a dramatic test - attempting the first live vaccine to fight malaria.
Physician leads efforts to rid world of malaria
In an interview with the student newspaper for the University of Georgia, Sanaria's Dr. Stephen Hoffman discusses his efforts to develop a malaria vaccine.
Sanaria and Sanaria’s CEO, Dr. Stephen L. Hoffman, featured in Esquire magazine
In the December, 2008 issue of Esquire, read the great discussion of malaria and the critical, innovative work that Sanaria is doing to develop new vaccines.
